362 related articles for article (PubMed ID: 28185143)
1. Characterization of 1-Aminobenzotriazole and Ketoconazole as Novel Inhibitors of Monoamine Oxidase (MAO): An In Vitro Investigation.
Shaik AN; LeDuc BW; Khan AA
Eur J Drug Metab Pharmacokinet; 2017 Oct; 42(5):827-834. PubMed ID: 28185143
[TBL] [Abstract][Full Text] [Related]
2. CYP-dependent metabolism of PF9601N, a new monoamine oxidase-B inhibitor, by C57BL/6 mouse and human liver microsomes.
Dragoni S; Materozzi G; Pessina F; Frosini M; Marco JL; Unzeta M; Sgaragli G; Valoti M
J Pharm Pharm Sci; 2007; 10(4):473-85. PubMed ID: 18261369
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver.
Ozaita A; Olmos G; Boronat MA; Lizcano JM; Unzeta M; García-Sevilla JA
Br J Pharmacol; 1997 Jul; 121(5):901-12. PubMed ID: 9222546
[TBL] [Abstract][Full Text] [Related]
4. Cytochrome P450-dependent N-dealkylation of L-deprenyl in C57BL mouse liver microsomes: effects of in vivo pretreatment with ethanol, phenobarbital, beta-naphthoflavone and L-deprenyl.
Valoti M; Fusi F; Frosini M; Pessina F; Tipton KF; Sgaragli GP
Eur J Pharmacol; 2000 Mar; 391(3):199-206. PubMed ID: 10729359
[TBL] [Abstract][Full Text] [Related]
5. 1,4-Benzoquinone as a new inhibitor of monoamine oxidase.
Naoi M; Nomura Y; Ishiki R; Suzuki H; Nagatsu T
Neurosci Lett; 1987 Jun; 77(2):215-20. PubMed ID: 3601232
[TBL] [Abstract][Full Text] [Related]
6. Metabolism of primaquine by liver homogenate fractions. Evidence for monoamine oxidase and cytochrome P450 involvement in the oxidative deamination of primaquine to carboxyprimaquine.
Constantino L; Paixão P; Moreira R; Portela MJ; Do Rosario VE; Iley J
Exp Toxicol Pathol; 1999 Jul; 51(4-5):299-303. PubMed ID: 10445386
[TBL] [Abstract][Full Text] [Related]
7. In vitro monoamine oxidase inhibition potential of alpha-methyltryptamine analog new psychoactive substances for assessing possible toxic risks.
Wagmann L; Brandt SD; Kavanagh PV; Maurer HH; Meyer MR
Toxicol Lett; 2017 Apr; 272():84-93. PubMed ID: 28302559
[TBL] [Abstract][Full Text] [Related]
8. Rasagiline [N-propargyl-1R(+)-aminoindan], a selective and potent inhibitor of mitochondrial monoamine oxidase B.
Youdim MB; Gross A; Finberg JP
Br J Pharmacol; 2001 Jan; 132(2):500-6. PubMed ID: 11159700
[TBL] [Abstract][Full Text] [Related]
9. Metabolism and clinical pharmacokinetics of 2-methyl-n-(2'-(pyrrolidinyl-1-ylsulfonyl)-n-[1,1'-biphenyl]-4-yl)propran-1-amine: insights into monoamine oxidase- and CYP-mediated disposition by integration of in vitro ADME tools.
Sawant Basak A; Byon W; Tseng-Lovering E; Funk C; Wood L; Lin C; Delnomdedieu M; Verhoest P; Parikh V; Cox LM; Miller E; Gao H; Obach RS
Xenobiotica; 2014 May; 44(5):438-54. PubMed ID: 24304147
[TBL] [Abstract][Full Text] [Related]
10. A high-throughput monoamine oxidase inhibition assay using liquid chromatography with tandem mass spectrometry.
Yan Z; Caldwell GW; Zhao B; Reitz AB
Rapid Commun Mass Spectrom; 2004; 18(8):834-40. PubMed ID: 15095350
[TBL] [Abstract][Full Text] [Related]
11. Bromo-dragonfly, a psychoactive benzodifuran, is resistant to hepatic metabolism and potently inhibits monoamine oxidase A.
Noble C; Holm NB; Mardal M; Linnet K
Toxicol Lett; 2018 Oct; 295():397-407. PubMed ID: 30036687
[TBL] [Abstract][Full Text] [Related]
12. Distinct effects of form selective cytochrome P450 inhibitors on cytochrome P450-mediated monooxygenase and hydrogen peroxide generating NADPH oxidase.
Mishin V; Heck DE; Jan YH; Richardson JR; Laskin JD
Toxicol Appl Pharmacol; 2022 Nov; 455():116258. PubMed ID: 36174671
[TBL] [Abstract][Full Text] [Related]
13. In vitro metabolism of the analgesic bicifadine in the mouse, rat, monkey, and human.
Erickson DA; Hollfelder S; Tenge J; Gohdes M; Burkhardt JJ; Krieter PA
Drug Metab Dispos; 2007 Dec; 35(12):2232-41. PubMed ID: 17881661
[TBL] [Abstract][Full Text] [Related]
14. Inhibition effects of Vernonia cinerea active compounds against cytochrome P450 2A6 and human monoamine oxidases, possible targets for reduction of tobacco dependence.
Prasopthum A; Pouyfung P; Sarapusit S; Srisook E; Rongnoparut P
Drug Metab Pharmacokinet; 2015 Apr; 30(2):174-81. PubMed ID: 25857233
[TBL] [Abstract][Full Text] [Related]
15. Methoxsalen as an in vitro phenotyping tool in comparison with 1-aminobenzotriazole.
Palacharla RC; Molgara P; Panthangi HR; Boggavarapu RK; Manoharan AK; Ponnamaneni RK; Ajjala DR; Nirogi R
Xenobiotica; 2019 Feb; 49(2):169-176. PubMed ID: 29382249
[TBL] [Abstract][Full Text] [Related]
16. Effects of CYP inhibitors on precocene I metabolism and toxicity in rat liver slices.
Ly VT; Brock B
Chem Biol Interact; 2011 Sep; 193(2):109-18. PubMed ID: 21741958
[TBL] [Abstract][Full Text] [Related]
17. Differential substrate specificity of monoamine oxidase in the rat heart and renal cortex.
Guimarães JT; Vindis C; Soares-da-Silva P; Parini A
Life Sci; 2003 Jul; 73(8):955-67. PubMed ID: 12818349
[TBL] [Abstract][Full Text] [Related]
18. Novel polyamine analogues: from substrates towards potential inhibitors of monoamine oxidases.
Bonaiuto E; Milelli A; Cozza G; Tumiatti V; Marchetti C; Agostinelli E; Fimognari C; Hrelia P; Minarini A; Di Paolo ML
Eur J Med Chem; 2013; 70():88-101. PubMed ID: 24140951
[TBL] [Abstract][Full Text] [Related]
19. Flavokawain A inhibits Cytochrome P450 in in vitro metabolic and inhibitory investigations.
Niu L; Ding L; Lu C; Zuo F; Yao K; Xu S; Li W; Yang D; Xu X
J Ethnopharmacol; 2016 Sep; 191():350-359. PubMed ID: 27318274
[TBL] [Abstract][Full Text] [Related]
20. Different sensitivity of mitochondrial and cytosolic monoamine oxidases to in vivo but not in vitro inhibition by specific irreversible inhibitors.
Moskvitina TA; Medvedev AE
Med Sci Monit; 2001; 7(1):17-9. PubMed ID: 11208486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
